Introduction dialysis ( HD) in December 1994 (three sessions of 3 h/week). Her dry weight was 55.3 kg.
The patient remained normotensive and had an The first successful term pregnancy occurring in a 35-uneventful dialysis course until presenting in September year-old dialysed patient was described in 1971 by 1995 with severe abdominal pain. A pelvic ultrasound Confortini et al. [1] . Since then we have been able to identify 120 published cases of conception occurring revealed a single live 7-weeks-old intrauterine gestation. in end-stage renal disease ( ESRD) patients*. In almost The calculated residual creatinine clearance was 30 years, the frequency of conception on dialysis has 13 ml/min. Following extensive counselling at the increased, the outcome of such pregnancies has Division of Maternal-Fetal Medicine regarding risks improved, and the overall attitude towards this com-of prematurity, pregnancy-induced hypertension, and plex clinical situation has evolved. We report the neonatal morbidity, the patient elected to continue successful multidisciplinary management of a preg-with the pregnancy. nancy in a haemodialysed patient from our centre. We A joint renal/obstetric HD protocol was designed to then propose practical guidelines for the management maintain a predialysis BUN <50 mg/dl, increasing her of such pregnancies based on a careful review of the HD session time to 4 h, and frequency to 4 times/ literature. Our literature search identified 120 cases of week. She had been dialysed with a biocompatible pregnancy occurring in dialysed patients, published high-flux polysulphone membrane (1.8 m2) until the between 1971 and 1998, allowing us to compare this pregnancy was diagnosed. She was then changed to a series to the previously published ones.
smaller surface area membrane (1.0 m2), and no reprocessed membranes were used. Standard bicarbonate with glucose, 3.0 mEq/l calcium, and a 3.0 mEq/l Case potassium dialysate was used. During each dialysis session the blood flow was gradually increased over A 32-year-old African-American female, gravida four, the first 30 min of HD, from 180 to 300 ml/min, while para two, aborta one, was diagnosed with renal monitoring the maternal blood pressure. Her Kt/V insufficiency in January 1993. She had no significant ranged between 1.02 and 1.66. past medical or surgical history, and she had experiDialysis was performed with the patient in the left enced two previous uneventful term vaginal deliveries. lateral decubitus position. The estimated maternal dry Renal insufficiency was managed expectantly until weight ( EDW ) was increased by 500 g every 10 days, October 1994, when she was admitted for acute renal corresponding to the usual maternal weight gain in a failure and massive nephrotic syndrome (proteinuria normal pregnancy. Standard heparin was used for anticoagulation, and daily low-dose aspirin was given Correspondence and offprint requests to: Dr D. P. Levy, The Center to prevent pre-eclampsia. Erythropoietin ( Epo) was (1 mg q.d.), and prenatal vitamins. The patient had *Interested readers can obtain the complete list of corresponding references from the editorial office.
evidence of protein-calorie malnutrition during the 8 © 1998 European Renal Association-European Dialysis and Transplant Association Pregnancy during dialysis-management guidelines 3267 months prior to pregnancy (serum albumin 1.9 g/l ). Frequency and outcome of pregnancy in dialysis When her pregnancy was diagnosed, a 3000 kcal/day patients diet was encouraged with more than 100 g of protein a day. Her serum albumin increased to 2.9-3.3 g/l and Pregnancy appears to be very rare among patients with remained in this range until delivery.
end-stage renal disease ( ESRD). It is difficult, however, Obstetric surveillance consisted of careful mon-to estimate the actual incidence of conception during itoring of maternal blood pressure, uterine and umbil-ESRD. This is because most published case reports ical artery perfusion, and continuous fetal heart rate only describe successful pregnancy outcomes, and an tracing immediately before, during, and immediately organized registry of these cases is only available in after each HD session from 25 weeks of gestation few countries. In addition, data collection may be until delivery. Uterine and umbilical artery perfusion incomplete, and many pregnancies are lost before they were assessed using systolic/diastolic (S/D) ratios, by are clinically confirmed. Three surveys have estimated Doppler velocimetry. Mean uterine artery S/D ratios the incidence of pregnancy in childbearing age women (±standard deviations) were 2.32 (0.53) before, 2.23 on dialysis to be between 0.75 and 7% [2] [3] [4] . In a very (0.45) during, and 2.52 (0.40) after HD, while mean recent Belgian survey, the incidence of conception was umbilical artery S/D ratios were 2.66 (0.34) before, estimated to be of 0.3 pregnancies for 100 patient-2.59 (0.45) during, and 2.52 (0.40) after HD. There years [5] . In our review, 47% of the reported pregnanwere no significant changes in uterine or umbilical cies occurred during the first 2 years on dialysis, while artery S/D ratios when compared before and during, women who were on dialysis for more than 10 years or before and after HD throughout gestation. There appeared less likely to conceive and accounted for only were no significant alterations in maternal mean arter-six of the 120 pregnancies. ial blood pressure during HD (range 73-106 mmHg).
The chances of a fetus surviving pregnancy on HD Continuous fetal heart tracings during HD remained are even more difficult to assess. The same three surveys reassuring at all times, with no changes in baseline have reported a 19-30% successful pregnancy rate variability or incidence of decelerations.
before 1990 although the likelihood of completing a The patient's obstetric course was otherwise uncom-term pregnancy has risen to 52% since then [6 ] plicated. The HD protocol was maintained unchanged Okundaye et al. [7] recently reporting the results of until 28 weeks gestation, when the patient developed the United States Registry, found an overall 40.2% of persistent headaches during the last part of each HD surviving infants when conception occurred after the session, which prompted a reduction in duration of beginning of dialysis. Table 1 shows the frequency and each HD session to 3.5 h. Maternal hypertension was outcome of pregnancy during dialysis in the previously never documented. Serial obstetric ultrasound exam-published series. In our review, 71% (n=39) of the 55 inations confirmed appropriate fetal growth.
cases published after 1990 resulted in a liveborn infant The patient was admitted at 31 weeks gestation for that survived, while only 57% (n=28) did before 1990. preterm labour, which was controlled with i.v. tocolysis It appears also that both conception and successful using intermittent boluses of magnesium sulphate to outcome are more likely to occur if some residual renal maintain a serum magnesium level of 6-8 mg/dl. She function is present [4] . Interestingly, the two latest also received betamethasone to maximize fetal lung surveys both suggest that increasing dialysis time maturity. She remained stable as an inpatient for the during pregnancy results in longer gestational period, next 2 weeks, with no changes required to her HD higher birth weight, and higher number of viable protocol. She developed premature rupture of mempregnancies [5, 7] . branes at 33 weeks gestation, which was followed soon Spontaneous abortions (SAB) (pregnancy loss after by a normal vaginal delivery of a liveborn female before 20 weeks of gestation), and stillbirths (preginfant, weighing 2168 g, with Apgar scores of 8 and 9.
nancy loss after 20 weeks of gestation) account for The patient had a completely uneventful postpartum nearly all pregnancy losses, with elective pregnancy course. Her renal disease has remained stable, now 24 termination and early neonatal deaths (in the first 7 months after this successful delivery. days of life) constituting the remainder. In our review, The neonate was admitted to the neonatal intensive 67 (64.5%) pregnancies resulted in a liveborn infant care unit immediately after birth, and was noted to that survived, with only 15 (16%) of all pregnancies have a haematocrit of 38% with a serum creatinine completing 36 weeks of gestation. Otherwise, the fetal level of 1.9 mg/dl. No polyuria was observed, and the outcome was remarkable for 12 (11.5%) SAB, eight creatinine dropped to 0.5 mg/dl within 6 days. The (7.7%) stillbirths, 14 (13.5%) early neonatal deaths, infant developed mild respiratory distress 6 h after four reported elective or medical terminations of pregbirth, consistent with transient tachypnea of the newnancy, and one infant demise 45 days after birth, this born, and she required supplemental oxygen only for information being available for 104 pregnancies out of a short period of time. After blood cultures were found 120 (see Table 2 ). to be positive for group B streptococcus, the baby One must acknowledge that the number of SAB is received a 10-day course of i.v. penicillin. All further probably underestimated because many pregnancies laboratory parameters remained stable. The infant was are lost before they have been recognized. Conversely, subsequently discharged home and is currently thriving at 24 months of age.
the incidence of stillbirths and early neonatal births are probably closer to the reality. In their latest review, Okundaye et al. [7] found 16.8% of SAB in the second trimester and 25% of SAB in the first trimester, 8.1% of stillbirths, and 8.2% of neonatal deaths, among 184 pregnancies (see Table 1 ). In the latter survey, the data was obtained by a very detailed questionnaire sent to the dialysis units, the resultant information was estimated to cover nearly 50% of women of childbearing age receiving dialysis in the United States. We suspect that the literature cases greatly underestimate the number of SAB, perhaps by eliminating or ignoring the early (first trimester) pregnancy losses. The great majority of the births in this population are preterm with a mean gestational age at delivery of 32.4 weeks [7] . In our review, the mean gestational age at delivery was 30.5 weeks ( Table 3 ). While previous studies suggested an increased risk of intrauterine growth restriction (IUGR) in pregnant HD patients, our review of the data does not support this conclusion. In the 92 cases for which information was available, birth weight appears appropriate for each gestational age at delivery, suggesting that the overall mean birth weight of 1.6 kg reflects increased incidence of prematurity rather than significant IUGR ( Table 4) .
Congenital abnormalities do not seem to be more frequent among HD patients than in the general population, whereas the incidence of polyhydramnios appears increased (22 of our 120 published cases). The pathophysiology of this excessive amniotic fluid production is unclear, with one of the suggested mechanisms being the solute diuresis, due to high blood urea concentration, by the normal fetal kidney [8] . The incidence of polyhydramnios may decrease with the use of chronic ambulatory peritoneal dialysis (CAPD) or with the increase of total dialysis time, where blood urea is kept in a low level.
Prescription of dialysis during pregnancy
In the literature the choice of the mode of dialysis is controversial. Peritoneal dialysis (PD) could improve the outcome of pregnancy among patients with ESRD [9] . However, the experience with PD in pregnancy is still limited to a very small number of cases, and most authors agree not to change the mode of dialysis after conception. More data still needs to be gathered concerning the outcome of pregnancies in PD patients and the incidence of eventual specific complications (e.g. peritonitis, catheter obstruction, and leak).
Neither have studies been published regarding the choice of dialysis membrane during pregnancy. Teratogenicity was described in animal studies and attributed to the use of formaldehyde and ethylene oxide. Thus, the use of a biocompatible membrane is recommended [10] . Biocompatible membranes also induce a lesser degree of net protein catabolism than bioincompatible membranes [11] . A smaller surface membrane combined with a longer dialysis time is preferred to a larger-surface dialyser with a standard session duration, as this minimizes fluid shifts, and 
86.6% (n=104) 64.5% (n=67) 11.5% (n=12) 7.7% (n=8) 13.5% (n=14) *Spontaneous abortions; defined as pregnancy loss before 20 weeks; **Stillbirths; defined as pregnancy loss after 20 weeks; ***Early neonatal deaths, defined as deaths occurring in the first week of life; †Percentages are based on totals, excluding cases with unknown information. avoids hypotensive episodes and abrupt osmolality or 1 pound per week. During the third trimester it is also useful to follow fetal weight and growth, using changes.
It is an arbitrary practice to keep BUN below serial ultrasound determinations. If weight gain is excessive, episodes of hypotension can be minimized 50 mg/dl. This goal may be difficult to obtain in women who have no residual renal function. Usually the by the use of isolated ultrafiltration. Scrupulous monitoring of maternal blood pressure and heart rate frequency of HD is increased to maintain a predialysis BUN under 50 mg/dl. The increase in dialysis time before, during, and after dialysis can also help the clinician estimate more accurately the amount of fluid seems to improve the pregnancy outcome and offers several advantages. It ensures a less uraemic environ-that has to be removed.
Dialysate potassium concentration may have to be ment for the fetus, and allows the mother a more liberal diet (protein and potassium) and fluid intake. increased to 3 or 3.5 mmol/l. Serum electrolytes need to be monitored weekly in order to avoid hypokalaeIt may help control hypertension, and may also reduce the amplitude of blood volume and electrolyte shifts. mia. The progesterone-induced increase in ventilation in normal pregnancy results in a respiratory alkalosis Frequent dialysis sessions make fluid removal and achievement of estimated dry weight ( EDW ) easier. It ( pCO 2 25-30 mEq/1). A secondary decrease in renal acidification reduces serum bicarbonate from 24-30 also lowers the risk of hypotension, which may be associated with fetal distress and premature labour.
mEq/l to 18-21 mEq/l. In patients with impaired renal function, this compensation cannot appropriately Maternal dry weight and weight gain need to be regularly re-evaluated according to changes in the take place. Therefore a low-bicarbonate dialysate (25 mEq/l ) has been recommended by Hou [2] . According estimated fetal weight. In the first trimester a minimal weight gain of 1-1.5 kg occurs. After the first trimester, to her experience, frequent HD may result in the transfer of excessive amounts of alkali to the mother, weight gain seems to be linear and amounts to 0.45 kg I. Giatras et al. 3270 thus generating substantial alkalaemia. In our case monitoring should begin at the time of fetal viability (25 weeks), until delivery. The frequent Doppler velocialkalaemia was not observed, although we used a standard bicarbonate dialysate. A careful monitoring metry measurements during our patient's pregnancy proved to be remarkably stable, unlike the results of the maternal respiratory rate, O 2 saturation, and electrolytes during HD is recommended. obtained by Oosterhof [15] . This may be the result of the precautions taken to ensure maternal haemoDuring normal pregnancy the digestive absorption of calcium is increased, physiological hypercalciuria dynamic stability during each HD sessions. Hypotensive episodes are known to be more frequent during and functional hyperparathyroidism occur, calcitriol levels increase, and parathyroid-hormone-related pep-the last 30 min of the dialysis treatment. Therefore we recommend continuous fetal heart monitoring towards tide (PTH-rp) levels increase [12] . In HD patients, calcium metabolism is also greatly altered, even though the end and shortly after each HD session. In addition serial obstetric ultrasound examinations should conhypercalciuria cannot occur. Both the calcium coming from the dialysate and the calcium ingested from firm appropriate fetal growth and estimate the amniotic fluid volume every 2-4 weeks. calcium carbonate used as a phosphate binding agent also need to be taken into account. A 3.5-mmol/l dialysate ensures a 1-g influx of calcium at each session,
Anaemia and iron management in pregnant dialysis
and this amount exceeds the cumulative amount of patients 25-30 g calcium required for calcification of the fetal skeleton. Daily HD with such a dialysate, however, can induce hypercalcaemia. A 2.5 mmol/l dialysate The first reported successful use of Epo during pregnancy in a HD patient was published in 1990 [16 ] . In needs to be supplemented with 1-2 g of oral calcium carbonate, to avoid overall calcium loss. A calcium-our review 24 of 120 patients were treated with Epo, representing only 65% of the pregnancies reported rich dialysate also appears to help control hyperphosphataemia and secondary hyperparathyroidism. after 1990. After 1992 Epo was used in 90% of the pregnancies. However, a drop in the haematocrit has These patients' calcium, phosphate levels should be monitored weekly, before and after HD. Hyper-been observed even during human recombinant Epotreated pregnancies, and blood transfusions may still phosphataemia can affect fetal skeletal development and frequent monitoring is mandatory if calcium be required. The Epo dose in such pregnancies is a matter of controversy. 
Fetal monitoring during haemodialysis
crosses the human placenta. Early concerns were based on animal studies using massive doses of Epo with deleterious effects on the murine fetus [19] . In humans, The few recommendations concerning fetal monitoring that have been published do not address the issue of strong indirect evidence argues against placental permeability to Epo. The absence of correlation between fetal assessment or fetal wellbeing during HD. Fetal surveillance during HD once fetal viability has been Epo levels in the mother and the fetus is an indirect indication that Epo levels are not in equilibrium across reached is of critical importance, given the acute fluid shifts that can occur and the resulting potential for the placenta [20] . The high molecular weight of Epo makes a passive diffusion through the placenta very acute hypotensive episodes. Significant changes in amniotic fluid have also been documented during HD, unlikely and there was no transfer observed in vitro with perfused human placenta [21] . Finally there seems which further emphasizes the need for close fetal surveillance [14] . The objective should be to minimize to be no Epo receptors in human placenta [22] .
Therapeutic use of Epo in the mother is thus unlikely uteroplacental and fetal perfusion disturbances. In one study describing the Doppler assessment of uterine and to have any haematological consequence in the fetus.
The occurrence of hypertension with Epo treatment umbilical perfusion during HD, it was found that both pulsatility index of the umbilical artery and the fetal is thought to be secondary to the increase of red blood cell mass but the mechanism of hypertension in this heart rate increased significantly after HD, and it was postulated that this might reflect fetal hypovolaemia setting is probably multifactorial [23] . It is often difficult to know if hypertension is secondary to Epo due to acute fluid withdrawal [15] .
Obstetric surveillance should consist in careful mon-use, to pregnancy itself, or to the underlying renal disease. When the haematocrit is not corrected by Epo, itoring of maternal blood pressure before, during, and immediately after each HD session. Fetal heart rate or when hypertension disappears after delivery, the role of Epo in the pathogenesis of hypertension seems the degree of underlying illness rather than the overall nutritional status. Plasma volume increases by 50% unlikely.
Interestingly, Epo has been shown to improve sexual over the course of pregnancy, and this increase begins during the first trimester of pregnancy. The alterations function and to induce regular menstruation in some studies [24] . This effect could be mediated by a decrease in different plasma parameters should be taken into account when interpreting laboratory data in a pregin prolactin levels under Epo treatment [25] even though hormonal changes associated with Epo seem nant woman. It should be noted that in the dialysis population, most pregnancies are not diagnosed until only transitory [26 ] . The mechanism by which prolactin is decreased by Epo treatment is not known. The the second trimester, by which time these alterations in laboratory parameters would be expected to be improved sexual function reported with Epo treatment may be related to improvement in the general health manifest.
In HD patients losses of essential nutrients such as, status. Therefore Epo treatment may have other advantages than haematocrit increments.
amino acids, and water soluble vitamins into the dialysate contribute to the impaired nutritional status. Daily iron losses are increased during HD and are estimated to be 780 mg per year. Therefore, Grossman Grossman et al. propose the doubling of the usual dose of water-soluble vitamins for these patients [28] . et al. [27] recommend an i.v. 500-mg dose of iron, administered as soon as pregnancy is diagnosed if Vitamin A being fat-soluble, is not dialysable, and its supplementation is not indicated unless deficiency is transferrin saturation is lower than 30%. Oral iron absorption is poor in HD patients and many authors determined by measurement. Supplementation of other divalent cations and trace elements are rarely necessary. have proposed i.v. iron supplementation during dialysis sessions. Depending on the iron preparation used, i.v. The only exceptions are iron and calcium, as already discussed above. iron should be given in low doses (10-40 mg) at each dialysis session, or in higher doses (100-1000 mg) less frequently [28] . This substitution should be monitored
Infertility and contraception in ESRD patients
with transferrin saturation measurements (maintained over 30%) rather than with ferritin levels (which may reflect stores that are not available for haemoglobin It is well known that HD patients conceive rarely, making the clinical finding of pregnancy in ESRD production) [27] . Folic-acid deficiency in the first trimester of pregnancy has been associated with unusual and often unexpected. The subfertility of these patients is thought to be multifactorial. Their libido neural-tube defects. Dietary potassium restrictions, frequent in ESRD patients, are often associated with and sexual function are usually considerably altered.
Amenorrhoea and anovulation are present in more folate deficiency. The normal recommendations during pregnancy are 0.4 mg daily supplements; recent data than 50% of cases [32] . Prolactin and LH levels are usually increased and GnRH pulsatility altered. Other indicate that this dose should be increased to 0.8 mg in HD patients (making a total daily dose of factors such as malnutrition (vitamins, trace elements), uraemic toxins, uraemic neuropathy, and pharmaco-0.8-1 mg/day).
logical agents (antihypertensive drugs, anti-emetics, digoxin) are probably also involved in the infertility Nutrition during pregnancy and dialysis associated with haemodialysis [33] . Birth control is advisable for women who do not wish to conceive, especially if regular periods are still Malnutrition is common among HD patients. The nutritional problems of patients with ESRD have been present or if residual renal function is maintained.
Although a recent study reports the almost complete well described [29] , and are complicated by the nutritional requirements of pregnancy. It has been estimated absence of counselling of HD women by their primary care physicians, these issues should be addressed and that the minimal daily dietary protein intake (DPI ) in healthy individuals is approximately of 0.6 g/kg. For discussed with women of childbearing age [32] . The choice of a contraceptive method is often difficult. HD patients, a protein intake of 1.4 g/kg/day is needed to maintain a positive or neutral nitrogen balance Barrier methods (diaphragms and condoms) can be used safely, while intrauterine devices might be associduring non-dialysis days. Thus a minimum of 1.2 g/kg/day is suggested as the safe level of DPI [30] . ated with increased infection episodes and bleeding during HD. Oral contraceptives are safe in the absence The recommended DPI for a pregnant woman is 1.2-1.3 g/kg. Adding the DPI for HD patients, and of hypertension, diabetes, or active lupus erythematosus. Dialysis patients are usually hypoestrogenic the additional daily protein requirements for pregnancy, a pregnant HD patient should be ingesting and the use of combined oral contraceptive pills might protect their bone tissue already at risk from renal 1.8 g/kg/day of protein.
Serum albumin and transfemin are normally used osteodystrophy. Holley et al.
[32] report an early age for menopause to evaluate the adequacy of protein status. Serum albumin is probably the most extensively examined in HD patients (47 years old). No previous studies are available to confirm this finding. It could be integrated index of nutritional status, because of its easy availability and strong association with outcome (e.g. mortality) in the accelerated aging attributed to uraemia (the uraemic milieu may affect follicular development or in ESRD patients [31] . However, albumin may reflect 13. Zerwekh JE, Breslau NA. Human placental production of 1a, accelerate follicular atresia). One must acknowledge 25-dihydroxyvitamin D3: biochemical characterization and prothat HD women are often amenorrheic or have irreguduction in normal subjects and patients with pseudohypoparalar menses, making the determination of the exact age 
